John P. Butler, CEO and President at Akebia Therapeutics, Inc. (AKBA), bought 69,270 shares at $1.25 ($87K) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Seasonal purchase ($87k) by CEO and President — this insider has traded AKBA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AKBA | SELL | 2025-02-04 | $606K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $147K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $115K | — | Filing → |